Growth Hormone and Prolactin Release in Acromegalic Patients Following Metergoline Administration

Publisher Website
Google Scholar
Abstract
In six acromegalic patients oral administration of 4 mg of metergoline, an antiserotonin agent, produced a fall in plasma growth hormone (GH) and prolactin (PRL) concentrations. In the same patients, this inhibitory effect was observed after administration of dopaminergic drugs, L-Dopa and 2- Br-α-ergocryptine. Both GH and PRL levels remained suppressed during a 6 day course of treatment with metergoline. These results are consistent with the hypothesis that the inhibitory effect of metergoline on GH and PRL release is determined by inactivation of serotonin receptors in the hypothalamus or at the pituitary.